Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qingdao Haier Biomedical CoSHSE:688139 +1.04%82 FCF Yield % is 1.52 as of Jul. 30, 2026, which is 6% above its 10-year median of 1.43. GuruFocus rates SHSE:688139 with a GF Score™ of 82/100 and a GF Value™ of ¥36.05 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Qingdao Haier Biomedical Co ranks better than 61.38% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Qingdao Haier Biomedical Co's FCF Yield % or its related term are showing as below:
SHSE:688139'
s FCF Yield % Range Over the Past 10 Years
Min: 0.26 Med: 1.43 Max: 3.48
Current: 1.52
During the past 10 years, the highest FCF Yield % of Qingdao Haier Biomedical Co was 3.48%. The lowest was 0.26%. And the median was 1.43%.
SHSE:688139's FCF Yield % is ranked better than 61.38% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -0.405
vs SHSE:688139: 1.52
Qingdao Haier Biomedical Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Qingdao Haier Biomedical Co FCF Yield % Related Terms
Qingdao Haier Biomedical Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688139 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Qingdao Haier Biomedical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao Haier Biomedical Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Qingdao Haier Biomedical Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qingdao Haier Biomedical Co (SHSE:688139) has a FCF Yield % of 1.52 as of Jul. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Qingdao Haier Biomedical Co and its competitors. This is near median its historical median of 1.43. Over the past decade, Qingdao Haier Biomedical Co's FCF Yield % has ranged from 0.26 to 3.48. According to the industry distribution chart, Qingdao Haier Biomedical Co ranks #329 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 38.6%.
Is Qingdao Haier Biomedical Co's FCF Yield % too high?
Qingdao Haier Biomedical Co's current FCF Yield % of 1.52 is near median its 10-year median of 1.43. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 3.48. Based on the distribution chart, Qingdao Haier Biomedical Co ranks #329 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Qingdao Haier Biomedical Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Haier Biomedical Co's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qingdao Haier Biomedical Co ranks #329 out of 852 companies for FCF Yield %. This puts Qingdao Haier Biomedical Co in the upper half of its industry. Historically, Qingdao Haier Biomedical Co's own FCF Yield % has ranged from 0.26 to 3.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Qingdao Haier Biomedical Co and its competitors. Qingdao Haier Biomedical Co's current FCF Yield % is 1.52, which is near median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Haier Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co (SHSE:688139) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥36.05, compared to a current price of ¥28.18 — trading 21.8% below its estimated fair value. The current FCF Yield % is 1.52, which is near median its 10-year median of 1.43. Qingdao Haier Biomedical Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Qingdao Haier Biomedical Co (SHSE:688139), the current FCF Yield % is 1.52 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao Haier Biomedical Co (SHSE:688139) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co stock appears to be undervalued.
The current stock price of ¥28.18 is trading 21.8% below its estimated GF Value™ of ¥36.05.
GuruFocus considers Qingdao Haier Biomedical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688139:
FCF Yield %: 1.52 (near median its 10-year median of 1.43)
GF Value™: ¥36.05 vs. price of ¥28.18 (21.8% below fair value)
No single metric tells the full story. See the SHSE:688139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
82GF Score
Get the complete analysis for SHSE:688139
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688139 has been successfully added to your 
